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LV geometric changes. CMR may be an important diagnostic tech-
nique to guide the decision-making process. Our initial experience
has been encouraging, but future studies with a greater number of
patients and long-term follow-up are warranted.
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ardiac myxoma belongs to the possible findings in
a workup after cerebral stroke, despite being an uncom-
mon disease with an incidence of 0.5 per million pop-
ulation per year.1 After surgical removal, cardiac
myxoma has a recurrence rate of 2% to 3%, higher in patients
with familial myxomas (30%–75%).2,3 Most new tumors develop
in the atria. A local recurrence suggests incomplete resection at
the primary operation. Whether recurrent myxoma is a result of dis-
semination of tumor cells at the first surgical procedure or a multi-
focal disease remains unclear.4 Since the introduction of
echocardiography and cardiac magnetic resonance (CMR) imag-
ing, the follow-up of these patients has improved.
Clinical Summary
In June of 2005, a 55-year-old female patient, previously healthy
without medication or allergies, presented with a left-sided hemipa-
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puted tomography scan displayed a 1-cm frontotemporal lesion
without bleeding. Her symptoms abated in 24 hours. Electrocardiog-
raphy showed normal sinus rhythm, and the chest x-ray was normal.
Transthoracic echocardiography (TTE) revealed a myxoma in the
left atrium. The tumor was removed with a biatrial approach under
cardioplegic arrest. The postoperative course was uneventful. His-
tology showed a benign myxoma with an undetermined surgical
margin toward the insertion point.
In December of 2005, the patient had a new stroke. Recurrent
myxoma was suspected. However, several echocardiograms (trans-
thoracic and transesophageal) and a CMR study in April of 2006
showed normal results (Figure 1, A). Carotid ultrasound showed
no plaques. Immunologic studies revealed normal immunoglobu-
lins and positive test results for antinuclear antibodies and rheuma-
toid factor. Anti-citrullin antibodies, extractable nuclear antigen,
and antineutrophil antibodies were negative. Lyme disease was
ruled out. Lupus anticoagulant was found, with negative anticardio-
lipin antibodies but no sign of cutaneous vasculitis. The workup im-
plicated cerebral vasculitis; thus, a high-dose steroid regimen was
begun and acetylsalicylic acid was administered. A cerebral 4-ves-
sel angiography was performed that showed small aneurysms (Fig-
ure 2). The tentative diagnosis was fusiform cerebral aneurysms
after myxoma surgery, and during an outpatient consultation the pa-
tient was recommended to undergo an annual TTE and a cerebral
biopsy to confirm the diagnosis. On the following day, the patient
returned to her local hospital with a new stroke. TTE detected a
tumor in the apical part of the left ventricle (LV). On CMR, the
tumor measured 23 3 27 mm with its base at the midportion of
the lateral wall (Figure 1, B). Reevaluation of all imaging studies
did not reveal any previous signs of ventricular myxoma. The pa-
tient was taken to surgery. Heparin-coated tubing was used in the
bypass circuit to reduce the heparin dose and prevent bleedingay 2008
Brief CommunicationsFigure 1. A, CMR examination in April
2006 without recurrence in the LV. B,
CMR, December 2006, displays the tu-
mor recurrence apically in the LV. No
signs of pericardial effusion or extrac-
ardial tumor. C, resected specimen
including trabeculae and papillary mus-
cles of the LV.complications. The left atrium was opened without signs of recur-
rence. An aortotomy displayed the myxoma but did not allow
a safe resection. An alternative approach was selected by an ante-
roapical incision into the LV. The tumor was adherent to a large
part of the LV trabecula, and part of the myocardium and the pap-
illary muscles had to be resected with the tumor (Figure 1, C). The
mitral valve was excised through the left atrial incision, and a bio-
logical prosthesis was implanted. The postoperative course was un-
eventful, and histology confirmed the diagnosis of myxoma, with
Figure 2. Cerebral angiogram showing varying caliber of the
cerebral vessels and fusiform aneurysms (white arrow).The Journal of Thorano signs of malignant transformation. On follow-up 2 and 6 months
after surgery, the patient is doing well. CMR shows no signs of re-
currence.
Discussion
The recurrence of myxoma after primary surgery is rare.1 Recur-
rences may occur during a time span from 6 months to 11 years after
the surgical removal.3 The association between cerebral aneurysms
and previous cardiac myxoma is rare, and since the first report in
1894 only 40 cases have been reported in the literature. The majority
of these cerebral aneurysms are associated with left atrial myxomas
(91%). The favored hypothesis is that cardiac embolic material dam-
age the vasa vasorum of the cerebral vessels leading to the formation
of aneurysm.5 Clinically, there was a strong suspicion of recurrence
of the myxoma, but neither echocardiography nor CMR could verify
this. The rapid growth is remarkable, with no signs on a TTE 3
months before the tumor was found in the LV. Only 3 reports
have been published4 of recurrent LV myxoma after the primary tu-
mor was found in the left atrium. Recurrent stroke in a patient with
previous myxoma surgery should prompt intensive efforts to detect
a recurrent tumor in the entire heart. The appearance of cerebral
fusiform aneurysm postoperatively can be associated with the pri-
mary tumor but does not preclude the possibility of late recurrence.
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